Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBF

Recent news which mentions RHHBF

< Previous 1 2 3 4 5 Next >
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHBY Hepatocellular Carcinoma General
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags NVS SNY Briefs
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags Health Care Biotech Benzinga
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags Briefs News NVS
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags Health Care BIIB Non Hodgkin Lymphoma
From Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Biotech Health Care Market News
From Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
Tickers RHHBF RHHBY RHHVF
Tags General RHHBY Health Care
From Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags FDA Benzinga Trading Ideas
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags General RHHBY Movers
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags Biotech Health Care Buybacks
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags AVIR RHHVF RHHBF
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Biotech Health Care Market News
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags General RHHBY Briefs
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags Briefs News RHHBY
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Market News Phase 2 Trial Benzinga
From Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF COVID/19 Coronavirus
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
Tickers IMCR RHHBF RHHBY RHHVF
Tags Health Care Biotech Small Cap
From Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
Tickers ABT BDX CI CVS
Tags Insurance Government Diagnostics
From Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags Market News ALPMY Trading Ideas
From Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Biotech Phase 1 Trial European Medicines Agency
From Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Tickers ALNY BIIB BMRN DRNA
Tags Trading Ideas NTLA DRNA
From Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF RHHBY
From Benzinga
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
Tickers AVIR RHHBF RHHBY RHHVF
Tags RHHBF RHHVF AVIR
From Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags European Medicines Agency REGN Health Care
From Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
Tickers REGN RHHBF RHHBY RHHVF
Tags Biotech Health Care European Medicines Agency
From Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
Tickers BIIB LLY RHHBF RHHBY
Tags RHHBY General News
From Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
Tickers ALXO MRK RHHBF RHHBY
Tags Market News MRK Trading Ideas
From Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
Tickers REGN RHHBF RHHBY RHHVF
Tags Benzinga Market News REGN
From Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
Tickers NVS RHHBF RHHBY RHHVF
Tags Market News Benzinga Biotech
From Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
Tickers GLTO RHHBF RHHBY RHHVF
Tags Phase 2 Trial Market News Benzinga
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.